Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-0706
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
American Association for Cancer Research (AACR)